Early Detection of Cancer and Hepatitis
The Institute for Hepatitis and Virus Research (IHVR) is using state-of-the-art
mass spectroscopy-assisted discovery of antigenic epitopes from
hepatitis B and C-infected cells, as well as other technologies
to discover epitopes that might have therapeutic value and serve
as early detection markers of cancer. New assays for the detection
of liver cancer and colorectal cancer are also being developed,
using novel genomic and proteomic methods.